Inhibition of NADPH-cytochrome P450 reductase by cyclophosphamide and its metabolites☆
References (20)
- et al.
Biochem. Biophys. Res. Commun
(1980) - et al.
Biochem. Biophys. Res. Commun
(1978) - et al.
Pharmac. Ther
(1980) - et al.
J. Biol. Chem
(1951) - et al.
J. Biol. Chem
(1976) - et al.
J. Biol. Chem
(1968) - et al.
J. Biol. Chem
(1965)
There are more references available in the full text version of this article.
Cited by (25)
Cytochrome P450 activation of toxins and hepatotoxicity
2013, Drug-Induced Liver DiseasePotential biological functions of cytochrome P450 reductase-dependent enzymes in small intestine: Novel link to expression of major histocompatibility complex class II genes
2012, Journal of Biological ChemistryCitation Excerpt :This finding, which defines a new physiological/pathological role of intestinal POR/P450 enzymes in modulating the expression of regulators of intestinal immunity, may have important clinical significance. POR is a direct target of inhibition by various drugs and other xenobiotic compounds (e.g. cyclophosphamide (57), ellipticine (58), and cadmium (59)). Furthermore, numerous genetic polymorphisms of the human POR gene that affect either POR expression or POR activity have been identified (60–63).
Reproductive toxicity of cyclophosphamide in the C57BL/6N mouse: 2. Effects on uterine structure and function
1992, Reproductive ToxicologyPhosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide
1991, Toxicology and Applied Pharmacology
- ☆
This work was supported by USPHS Grants CA-23634 (HLG, RFS) and CA-13038 from the National Cancer Institute, Bethesda, MD.
Copyright © 1981 Published by Elsevier Inc.